Posters Overview
Therapeutic peptide drugs demonstrate significant clinical potential due to their high specificity, strong target affinity, and superior tissue permeability. However, their short half-life often leads to rapid systemic clearance. To overcome these limitations, several strategies have been developed to prolong half-life and enhance efficacy, such as Fc-fusion and antibody conjugation, and so on. In particular, with the increasing application of GLP-1-based fusion proteins in treating obesity and diabetes, understanding and optimizing their pharmacokinetic properties is essential.

Complete the form to view and download this poster.
Stay Connected
Keep up with the latest news and insights.